Paragon Capital Management Ltd Has $433,000 Stake in Colgate-Palmolive (NYSE:CL)

Paragon Capital Management Ltd lowered its holdings in Colgate-Palmolive (NYSE:CL) by 19.7% during the first quarter, according to the company in its most recent Form 13F filing with the SEC. The institutional investor owned 4,808 shares of the company’s stock after selling 1,177 shares during the quarter. Paragon Capital Management Ltd’s holdings in Colgate-Palmolive were worth $433,000 as of its most recent filing with the SEC.

Other hedge funds have also modified their holdings of the company. Douglas Lane & Associates LLC increased its position in shares of Colgate-Palmolive by 0.7% during the first quarter. Douglas Lane & Associates LLC now owns 21,836 shares of the company’s stock worth $1,966,000 after acquiring an additional 152 shares in the last quarter. &PARTNERS grew its holdings in shares of Colgate-Palmolive by 1.4% during the first quarter. &PARTNERS now owns 17,885 shares of the company’s stock worth $1,611,000 after buying an additional 242 shares in the last quarter. Central Bank & Trust Co. raised its position in Colgate-Palmolive by 11.6% in the 1st quarter. Central Bank & Trust Co. now owns 1,544 shares of the company’s stock valued at $139,000 after buying an additional 161 shares during the last quarter. Gulf International Bank UK Ltd lifted its stake in Colgate-Palmolive by 9.5% in the 1st quarter. Gulf International Bank UK Ltd now owns 87,008 shares of the company’s stock valued at $7,835,000 after acquiring an additional 7,532 shares in the last quarter. Finally, First Affirmative Financial Network boosted its position in Colgate-Palmolive by 6.5% during the 1st quarter. First Affirmative Financial Network now owns 3,793 shares of the company’s stock worth $342,000 after acquiring an additional 230 shares during the last quarter. 80.41% of the stock is owned by institutional investors.

Colgate-Palmolive Trading Up 0.3 %

NYSE CL traded up $0.32 during trading hours on Friday, hitting $97.27. 6,378,293 shares of the company’s stock were exchanged, compared to its average volume of 3,211,211. The company has a current ratio of 1.06, a quick ratio of 0.70 and a debt-to-equity ratio of 13.21. Colgate-Palmolive has a 1-year low of $67.62 and a 1-year high of $97.67. The stock has a 50-day simple moving average of $92.71 and a 200 day simple moving average of $86.85. The firm has a market cap of $79.80 billion, a price-to-earnings ratio of 30.78, a PEG ratio of 3.57 and a beta of 0.39.

Colgate-Palmolive (NYSE:CL) last posted its quarterly earnings results on Friday, April 26th. The company reported $0.86 earnings per share for the quarter, beating the consensus estimate of $0.82 by $0.04. The firm had revenue of $5.07 billion during the quarter, compared to the consensus estimate of $4.96 billion. Colgate-Palmolive had a net margin of 13.22% and a return on equity of 485.40%. The business’s revenue was up 6.2% compared to the same quarter last year. During the same period in the previous year, the firm posted $0.73 earnings per share. On average, equities analysts forecast that Colgate-Palmolive will post 3.53 EPS for the current fiscal year.

Colgate-Palmolive Announces Dividend

The company also recently disclosed a quarterly dividend, which will be paid on Thursday, August 15th. Stockholders of record on Friday, July 19th will be issued a dividend of $0.50 per share. The ex-dividend date is Friday, July 19th. This represents a $2.00 annualized dividend and a dividend yield of 2.06%. Colgate-Palmolive’s dividend payout ratio is 63.29%.

Analyst Upgrades and Downgrades

A number of equities research analysts have recently issued reports on CL shares. Barclays upped their price objective on Colgate-Palmolive from $84.00 to $85.00 and gave the stock an “equal weight” rating in a research note on Tuesday, April 30th. Wells Fargo & Company raised their target price on shares of Colgate-Palmolive from $90.00 to $92.00 and gave the company an “equal weight” rating in a research note on Monday, April 29th. Evercore ISI raised their price objective on Colgate-Palmolive from $90.00 to $96.00 and gave the company an “outperform” rating in a research report on Monday, April 8th. Argus raised their price target on Colgate-Palmolive from $97.00 to $107.00 and gave the company a “buy” rating in a report on Wednesday, May 15th. Finally, Morgan Stanley increased their target price on shares of Colgate-Palmolive from $101.00 to $103.00 and gave the stock an “overweight” rating in a research report on Tuesday, May 28th. Three analysts have rated the stock with a hold rating and fourteen have assigned a buy rating to the company. Based on data from MarketBeat, Colgate-Palmolive has a consensus rating of “Moderate Buy” and an average target price of $92.94.

Insiders Place Their Bets

In other Colgate-Palmolive news, insider Sally Massey sold 12,226 shares of Colgate-Palmolive stock in a transaction dated Thursday, May 9th. The stock was sold at an average price of $94.06, for a total transaction of $1,149,977.56. Following the completion of the transaction, the insider now owns 13,924 shares in the company, valued at approximately $1,309,691.44. The transaction was disclosed in a document filed with the Securities & Exchange Commission, which is available through the SEC website. In other Colgate-Palmolive news, insider Sally Massey sold 12,226 shares of Colgate-Palmolive stock in a transaction on Thursday, May 9th. The shares were sold at an average price of $94.06, for a total transaction of $1,149,977.56. Following the transaction, the insider now directly owns 13,924 shares of the company’s stock, valued at approximately $1,309,691.44. The transaction was disclosed in a legal filing with the Securities & Exchange Commission, which is available through this hyperlink. Also, insider John W. Kooyman sold 3,497 shares of the stock in a transaction dated Tuesday, May 7th. The shares were sold at an average price of $93.47, for a total transaction of $326,864.59. Following the completion of the sale, the insider now owns 3,181 shares of the company’s stock, valued at approximately $297,328.07. The disclosure for this sale can be found here. Corporate insiders own 0.34% of the company’s stock.

About Colgate-Palmolive

Colgate-Palmolive Company, together with its subsidiaries, manufactures and sells consumer products in the United States and internationally. It operates through two segments: Oral, Personal and Home Care; and Pet Nutrition. The Oral, Personal and Home Care segment offers toothpaste, toothbrushes, mouthwash, bar and liquid hand soaps, shower gels, shampoos, conditioners, deodorants and antiperspirants, skin health products, dishwashing detergents, fabric conditioners, household cleaners, and other related items.